Cite

HARVARD Citation

    Gadaleta-Caldarola, G. et al. (2015). Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond. Future oncology. pp. 2263-2266. [Online]. 
  
Back to record